Moderna Set To Start HIV mRNA Vaccine Human Trials
th, will conclude in spring of 2023.“The mRNA platform makes it easy to develop vaccines against variants because it just requires an update to the coding sequences in the mRNA that code for the variant,” Rajesh Gandhi, an infectious disease expert who chairs the HIV Medicine Association, told Verywell Health.“Based on its success in protecting against COVID-19, I am hopeful that mRNA technology will revolutionize our ability to develop vaccines against other pathogens, like HIV and influenza.”If phase one of the study is successful, a second and third phase will be undertaken to see exactly how effective these may be.But how exactly would these vaccines work? It all comes down to a piece of messenger RNA that codes a part of the virus in